nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC22A3—Irinotecan—stomach cancer	0.363	0.925	CbGbCtD
Methamphetamine—CYP2D6—Doxorubicin—stomach cancer	0.0295	0.075	CbGbCtD
Methamphetamine—SLC18A1—endocrine gland—stomach cancer	0.0116	0.0908	CbGeAlD
Methamphetamine—Phenformin—PRKAA1—stomach cancer	0.0111	0.324	CrCbGaD
Methamphetamine—SLC18A1—lymph node—stomach cancer	0.008	0.0628	CbGeAlD
Methamphetamine—SLC18A2—hematopoietic system—stomach cancer	0.00644	0.0505	CbGeAlD
Methamphetamine—SLC6A3—hematopoietic system—stomach cancer	0.00487	0.0382	CbGeAlD
Methamphetamine—SLC22A3—hematopoietic system—stomach cancer	0.00458	0.036	CbGeAlD
Methamphetamine—SLC18A2—digestive system—stomach cancer	0.00448	0.0351	CbGeAlD
Methamphetamine—SLC6A4—hematopoietic system—stomach cancer	0.00446	0.035	CbGeAlD
Methamphetamine—MAOB—hematopoietic system—stomach cancer	0.00424	0.0333	CbGeAlD
Methamphetamine—SLC22A3—smooth muscle tissue—stomach cancer	0.00404	0.0317	CbGeAlD
Methamphetamine—SLC18A2—endocrine gland—stomach cancer	0.0037	0.029	CbGeAlD
Methamphetamine—MAOA—hematopoietic system—stomach cancer	0.00362	0.0284	CbGeAlD
Methamphetamine—Dexfenfluramine—CYP2A6—stomach cancer	0.00349	0.102	CrCbGaD
Methamphetamine—SLC18A2—liver—stomach cancer	0.00333	0.0262	CbGeAlD
Methamphetamine—SLC6A4—digestive system—stomach cancer	0.0031	0.0243	CbGeAlD
Methamphetamine—Lacosamide—CA1—stomach cancer	0.00304	0.089	CrCbGaD
Methamphetamine—MAOB—digestive system—stomach cancer	0.00295	0.0231	CbGeAlD
Methamphetamine—MAOA—pancreas—stomach cancer	0.00295	0.0231	CbGeAlD
Methamphetamine—ADRA2C—pancreas—stomach cancer	0.00283	0.0222	CbGeAlD
Methamphetamine—ADRA2A—hematopoietic system—stomach cancer	0.00278	0.0218	CbGeAlD
Methamphetamine—SLC22A3—endocrine gland—stomach cancer	0.00263	0.0207	CbGeAlD
Methamphetamine—SLC6A4—endocrine gland—stomach cancer	0.00256	0.0201	CbGeAlD
Methamphetamine—SLC18A2—lymph node—stomach cancer	0.00256	0.0201	CbGeAlD
Methamphetamine—MAOA—digestive system—stomach cancer	0.00252	0.0197	CbGeAlD
Methamphetamine—MAOB—endocrine gland—stomach cancer	0.00244	0.0191	CbGeAlD
Methamphetamine—SLC22A3—liver—stomach cancer	0.00237	0.0186	CbGeAlD
Methamphetamine—SLC22A5—digestive system—stomach cancer	0.00232	0.0182	CbGeAlD
Methamphetamine—Lacosamide—CA2—stomach cancer	0.0023	0.0674	CrCbGaD
Methamphetamine—ADRA2A—pancreas—stomach cancer	0.00226	0.0177	CbGeAlD
Methamphetamine—SLC6A2—endocrine gland—stomach cancer	0.00226	0.0177	CbGeAlD
Methamphetamine—MAOB—liver—stomach cancer	0.0022	0.0172	CbGeAlD
Methamphetamine—CYP2D6—hematopoietic system—stomach cancer	0.00215	0.0169	CbGeAlD
Methamphetamine—MAOA—endocrine gland—stomach cancer	0.00208	0.0163	CbGeAlD
Methamphetamine—MAOA—liver—stomach cancer	0.00188	0.0147	CbGeAlD
Methamphetamine—Phenylpropanolamine—ADRB1—stomach cancer	0.00183	0.0536	CrCbGaD
Methamphetamine—SLC22A3—lymph node—stomach cancer	0.00182	0.0143	CbGeAlD
Methamphetamine—ADRA2C—liver—stomach cancer	0.0018	0.0141	CbGeAlD
Methamphetamine—SLC22A5—liver—stomach cancer	0.00173	0.0135	CbGeAlD
Methamphetamine—Ephedrine—ADRB2—stomach cancer	0.00172	0.0503	CrCbGaD
Methamphetamine—MAOB—lymph node—stomach cancer	0.00168	0.0132	CbGeAlD
Methamphetamine—ADRA2A—endocrine gland—stomach cancer	0.0016	0.0125	CbGeAlD
Methamphetamine—SLC6A2—lymph node—stomach cancer	0.00156	0.0122	CbGeAlD
Methamphetamine—Selegiline—CYP2A6—stomach cancer	0.00156	0.0455	CrCbGaD
Methamphetamine—Pseudoephedrine—ADRB1—stomach cancer	0.00155	0.0453	CrCbGaD
Methamphetamine—Phenylpropanolamine—ADRB2—stomach cancer	0.00154	0.0451	CrCbGaD
Methamphetamine—CYP2D6—digestive system—stomach cancer	0.0015	0.0117	CbGeAlD
Methamphetamine—Pseudoephedrine—TNF—stomach cancer	0.00147	0.043	CrCbGaD
Methamphetamine—Nateglinide—PPARG—stomach cancer	0.00144	0.0422	CrCbGaD
Methamphetamine—MAOA—lymph node—stomach cancer	0.00144	0.0113	CbGeAlD
Methamphetamine—ADRA2C—lymph node—stomach cancer	0.00138	0.0108	CbGeAlD
Methamphetamine—SLC22A5—lymph node—stomach cancer	0.00132	0.0104	CbGeAlD
Methamphetamine—Pseudoephedrine—ADRB2—stomach cancer	0.0013	0.0381	CrCbGaD
Methamphetamine—Amphetamine—CYP2A6—stomach cancer	0.00129	0.0378	CrCbGaD
Methamphetamine—CYP2D6—endocrine gland—stomach cancer	0.00124	0.00969	CbGeAlD
Methamphetamine—CYP2D6—liver—stomach cancer	0.00111	0.00874	CbGeAlD
Methamphetamine—ADRA2A—lymph node—stomach cancer	0.0011	0.00865	CbGeAlD
Methamphetamine—Nateglinide—ALB—stomach cancer	0.000543	0.0159	CrCbGaD
Methamphetamine—TAAR1—Signaling Pathways—PIK3CA—stomach cancer	6.74e-05	0.000151	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RPS6—stomach cancer	6.67e-05	0.00015	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SREBF2—stomach cancer	6.63e-05	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPP2R1A—stomach cancer	6.63e-05	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—MAPK3—stomach cancer	6.62e-05	0.000149	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PRKCB—stomach cancer	6.56e-05	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HBEGF—stomach cancer	6.56e-05	0.000147	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—RORA—stomach cancer	6.55e-05	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—VEGFA—stomach cancer	6.54e-05	0.000147	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6ST—stomach cancer	6.53e-05	0.000147	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—stomach cancer	6.52e-05	0.000146	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—TP53—stomach cancer	6.52e-05	0.000146	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTP1—stomach cancer	6.5e-05	0.000146	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—MTHFR—stomach cancer	6.42e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HMOX1—stomach cancer	6.41e-05	0.000144	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CD44—stomach cancer	6.33e-05	0.000142	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—stomach cancer	6.31e-05	0.000142	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—MAPK1—stomach cancer	6.3e-05	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AGTR2—stomach cancer	6.3e-05	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HSPB1—stomach cancer	6.3e-05	0.000141	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6R—stomach cancer	6.24e-05	0.00014	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—HRAS—stomach cancer	6.24e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BMP2—stomach cancer	6.22e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—F2R—stomach cancer	6.22e-05	0.00014	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—RHOA—stomach cancer	6.21e-05	0.000139	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—MAPK3—stomach cancer	6.19e-05	0.000139	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALDOB—stomach cancer	6.14e-05	0.000138	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HBEGF—stomach cancer	6.13e-05	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKR1C3—stomach cancer	6.12e-05	0.000137	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR1A—stomach cancer	6.06e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRB2—stomach cancer	6.05e-05	0.000136	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—TYMS—stomach cancer	6.04e-05	0.000136	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—NOS3—stomach cancer	6.03e-05	0.000135	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GSTM1—stomach cancer	5.97e-05	0.000134	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—IL6—stomach cancer	5.97e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—KRAS—stomach cancer	5.95e-05	0.000134	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PPP2R1A—stomach cancer	5.93e-05	0.000133	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CAV1—stomach cancer	5.92e-05	0.000133	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—APOA1—stomach cancer	5.91e-05	0.000133	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—MAPK1—stomach cancer	5.89e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PRKCB—stomach cancer	5.87e-05	0.000132	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ANXA1—stomach cancer	5.85e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6R—stomach cancer	5.83e-05	0.000131	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—RHOA—stomach cancer	5.8e-05	0.00013	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALOX5—stomach cancer	5.7e-05	0.000128	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB1—stomach cancer	5.67e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRB2—stomach cancer	5.65e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—RHOA—stomach cancer	5.64e-05	0.000127	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ERCC2—stomach cancer	5.62e-05	0.000126	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—DPYD—stomach cancer	5.61e-05	0.000126	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—KRAS—stomach cancer	5.56e-05	0.000125	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PPP2R1A—stomach cancer	5.54e-05	0.000124	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—stomach cancer	5.52e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SMAD4—stomach cancer	5.51e-05	0.000124	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—PIK3CA—stomach cancer	5.47e-05	0.000123	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CXCL8—stomach cancer	5.45e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RPS6—stomach cancer	5.42e-05	0.000122	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPP2R1A—stomach cancer	5.38e-05	0.000121	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PRKCB—stomach cancer	5.33e-05	0.00012	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VEGFA—stomach cancer	5.31e-05	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6ST—stomach cancer	5.31e-05	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—TP53—stomach cancer	5.29e-05	0.000119	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTP1—stomach cancer	5.28e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—MTHFR—stomach cancer	5.28e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—RHOA—stomach cancer	5.27e-05	0.000118	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FYN—stomach cancer	5.23e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HMOX1—stomach cancer	5.21e-05	0.000117	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PPARG—stomach cancer	5.2e-05	0.000117	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SMAD4—stomach cancer	5.14e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—PIK3CA—stomach cancer	5.11e-05	0.000115	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CXCL8—stomach cancer	5.09e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—HRAS—stomach cancer	5.06e-05	0.000114	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—MAPK3—stomach cancer	5.03e-05	0.000113	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HBEGF—stomach cancer	4.98e-05	0.000112	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTT1—stomach cancer	4.96e-05	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CXCL8—stomach cancer	4.95e-05	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—TP53—stomach cancer	4.94e-05	0.000111	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGFR2—stomach cancer	4.91e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TYMS—stomach cancer	4.91e-05	0.00011	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP2A6—stomach cancer	4.91e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FYN—stomach cancer	4.88e-05	0.00011	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAV1—stomach cancer	4.87e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—APOA1—stomach cancer	4.86e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GSTM1—stomach cancer	4.85e-05	0.000109	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—MAPK1—stomach cancer	4.78e-05	0.000107	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKR1C3—stomach cancer	4.77e-05	0.000107	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6R—stomach cancer	4.73e-05	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—HRAS—stomach cancer	4.73e-05	0.000106	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—RHOA—stomach cancer	4.71e-05	0.000106	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—stomach cancer	4.68e-05	0.000105	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ENO1—stomach cancer	4.65e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CXCL8—stomach cancer	4.62e-05	0.000104	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	4.59e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGFR2—stomach cancer	4.59e-05	0.000103	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ERCC2—stomach cancer	4.56e-05	0.000102	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—KRAS—stomach cancer	4.52e-05	0.000101	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	4.5e-05	0.000101	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IRS2—stomach cancer	4.5e-05	0.000101	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—NOS3—stomach cancer	4.48e-05	0.0001	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CAV1—stomach cancer	4.36e-05	9.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOA1—stomach cancer	4.35e-05	9.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—MTHFR—stomach cancer	4.29e-05	9.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PPARG—stomach cancer	4.28e-05	9.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	4.28e-05	9.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IRS2—stomach cancer	4.2e-05	9.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	4.18e-05	9.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—PIK3CA—stomach cancer	4.15e-05	9.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCB—stomach cancer	4.15e-05	9.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	4.13e-05	9.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6ST—stomach cancer	4.13e-05	9.27e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CD44—stomach cancer	4.12e-05	9.26e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—stomach cancer	4.09e-05	9.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CAV1—stomach cancer	4.07e-05	9.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOA1—stomach cancer	4.06e-05	9.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—TP53—stomach cancer	4.01e-05	9.01e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PIK3CA—stomach cancer	4.01e-05	9.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APC—stomach cancer	3.97e-05	8.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FYN—stomach cancer	3.97e-05	8.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAV1—stomach cancer	3.95e-05	8.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOA1—stomach cancer	3.95e-05	8.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCB—stomach cancer	3.88e-05	8.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6ST—stomach cancer	3.86e-05	8.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—stomach cancer	3.85e-05	8.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—HRAS—stomach cancer	3.84e-05	8.62e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—MAPK3—stomach cancer	3.8e-05	8.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	3.75e-05	8.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	3.72e-05	8.36e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APC—stomach cancer	3.71e-05	8.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6R—stomach cancer	3.69e-05	8.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—NOS3—stomach cancer	3.68e-05	8.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	3.62e-05	8.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	3.62e-05	8.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—MAPK3—stomach cancer	3.55e-05	7.97e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	3.51e-05	7.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PPARG—stomach cancer	3.48e-05	7.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	3.46e-05	7.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	3.45e-05	7.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6R—stomach cancer	3.44e-05	7.73e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTP1—stomach cancer	3.44e-05	7.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	3.42e-05	7.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	3.41e-05	7.65e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PIK3CA—stomach cancer	3.4e-05	7.62e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMOX1—stomach cancer	3.39e-05	7.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	3.38e-05	7.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	3.38e-05	7.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—stomach cancer	3.37e-05	7.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RHOA—stomach cancer	3.33e-05	7.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	3.31e-05	7.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	3.3e-05	7.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NOS3—stomach cancer	3.3e-05	7.4e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	3.23e-05	7.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	3.22e-05	7.24e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TYMS—stomach cancer	3.2e-05	7.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	3.19e-05	7.16e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GSTM1—stomach cancer	3.16e-05	7.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	3.15e-05	7.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	3.14e-05	7.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	3.13e-05	7.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—stomach cancer	3.13e-05	7.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RHOA—stomach cancer	3.11e-05	6.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	3.08e-05	6.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NOS3—stomach cancer	3.08e-05	6.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APC—stomach cancer	3.01e-05	6.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—NOS3—stomach cancer	2.99e-05	6.71e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ERCC2—stomach cancer	2.97e-05	6.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	2.93e-05	6.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	2.92e-05	6.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	2.9e-05	6.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	2.88e-05	6.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	2.88e-05	6.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	2.85e-05	6.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	2.8e-05	6.28e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—MTHFR—stomach cancer	2.79e-05	6.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	2.78e-05	6.24e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	2.74e-05	6.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	2.74e-05	6.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—stomach cancer	2.73e-05	6.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	2.73e-05	6.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	2.72e-05	6.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—JUN—stomach cancer	2.72e-05	6.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	2.71e-05	6.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	2.67e-05	5.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	2.64e-05	5.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	2.63e-05	5.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	2.62e-05	5.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	2.62e-05	5.88e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6—stomach cancer	2.6e-05	5.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	2.59e-05	5.82e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAV1—stomach cancer	2.58e-05	5.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	2.57e-05	5.77e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOA1—stomach cancer	2.57e-05	5.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCND1—stomach cancer	2.54e-05	5.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JUN—stomach cancer	2.54e-05	5.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	2.53e-05	5.67e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PIK3CA—stomach cancer	2.52e-05	5.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	2.5e-05	5.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—stomach cancer	2.47e-05	5.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	2.46e-05	5.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	2.4e-05	5.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	2.38e-05	5.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	2.37e-05	5.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	2.35e-05	5.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	2.34e-05	5.25e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PPARG—stomach cancer	2.27e-05	5.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	2.25e-05	5.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	2.22e-05	4.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	2.22e-05	4.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	2.2e-05	4.95e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	2.2e-05	4.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MYC—stomach cancer	2.18e-05	4.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	2.17e-05	4.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	2.14e-05	4.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	2.14e-05	4.8e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	2.11e-05	4.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	2.1e-05	4.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PIK3CA—stomach cancer	2.07e-05	4.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	2.07e-05	4.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JUN—stomach cancer	2.06e-05	4.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MYC—stomach cancer	2.04e-05	4.58e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—stomach cancer	2.04e-05	4.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	2.02e-05	4.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	2.01e-05	4.5e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	2e-05	4.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	2e-05	4.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	2e-05	4.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	1.95e-05	4.38e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—NOS3—stomach cancer	1.95e-05	4.37e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	1.89e-05	4.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1.85e-05	4.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	1.8e-05	4.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TP53—stomach cancer	1.79e-05	4.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	1.78e-05	4e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—stomach cancer	1.78e-05	4e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	1.73e-05	3.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.72e-05	3.85e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.7e-05	3.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.68e-05	3.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TP53—stomach cancer	1.68e-05	3.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.66e-05	3.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.64e-05	3.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.62e-05	3.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.62e-05	3.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.6e-05	3.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.53e-05	3.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.53e-05	3.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.41e-05	3.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.36e-05	3.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1.3e-05	2.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6—stomach cancer	1.25e-05	2.8e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.1e-05	2.46e-05	CbGpPWpGaD
